Nomogram Predicting Survival to Assist Decision-Making of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma

Nomogram Predicting Survival to Assist Decision-Making of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma

The survival benefit of metastasectomy (MSX) in patients with metastatic renal cell carcinoma (mRCC) remains unclear. A reliable model to predict an individuals’ risk of cancer-specific mortality (CSM) and to identify optimal candidates for MSX is needed. We identified 2,911 mRCC patients who underw...

Full description

Bibliographic Details
Main Authors: Kan Wu, Zhihong Liu, Yanxiang Shao, Xiang Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Oncology
Subjects:
metastatic renal cell carcinoma
metastasectomy
nomogram
cancer-specific mortality
cytoreductive nephrectomy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.592243/full

Similar Items

Similar Items